Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morphological changes in cultured myotubes treated with agents that interfere with lysosomal function

S Bursztajn, P Libby

    Cell and Tissue Research
    |January 1, 1981
    PubMed
    Summary

    Lysosomal inhibitors like chloroquine and leupeptin prevent acetylcholine receptor (AChR) degradation in muscle cells. This leads to receptor buildup and increased coated vesicles, suggesting impaired lysosome-vesicle fusion.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

    Alimentary pharmacology & therapeutics·2018
    Same author

    Inflammation and plaque vulnerability.

    Journal of internal medicine·2015
    Same author

    Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.

    Journal of thrombosis and haemostasis : JTH·2014
    Same author

    Cardiac transplant graft arteriosclerosis.

    Trends in cardiovascular medicine·2011
    Same author

    Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo.

    Thrombosis and haemostasis·2011
    Same author

    How our growing understanding of inflammation has reshaped the way we think of disease and drug development.

    Clinical pharmacology and therapeutics·2010

    Area of Science:

    • Cell biology
    • Muscle cell physiology
    • Receptor trafficking

    Background:

    • Lysosomes degrade cellular components, including acetylcholine receptors (AChR).
    • Inhibitors of lysosomal function impede this degradation process.
    • Coated vesicles are implicated in intracellular transport.

    Purpose of the Study:

    • To investigate the effects of leupeptin and chloroquine on cultured myotube morphology.
    • To understand acetylcholine receptor turnover and the origin of coated vesicles.
    • To elucidate the mechanism by which lysosomal inhibitors affect receptor degradation.

    Main Methods:

    • Treatment of cultured myotubes with leupeptin and chloroquine.
    • Morphological analysis using microscopy.

    Related Experiment Videos

  • Quantification of coated vesicle size and content (horseradish peroxidase uptake).
  • Main Results:

    • Chloroquine induced plasma membrane involution, sarcomere disorganization, vacuolization, and enlarged lysosome-like bodies.
    • Leupeptin enlarged dense bodies but did not cause vacuolization or sarcomere disruption.
    • Chloroquine treatment led to accumulation of large coated vesicles, while leupeptin treatment resulted in smaller coated vesicles. Chloroquine-treated cells showed increased horseradish peroxidase uptake in coated vesicles.

    Conclusions:

    • Chloroquine interferes with AChR degradation by inhibiting lysosome-coated vesicle fusion.
    • Leupeptin and chloroquine differentially affect myotube morphology and coated vesicle characteristics.
    • These findings provide insights into receptor turnover and the role of coated vesicles in muscle cells.